Cargando…

Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort

BACKGROUND: The objective of this study was to assess the treatment outcomes and prognostic factors of elderly patients with locally advanced head and neck cancer (LAHNC) undergoing radiotherapy (RT). MATERIALS AND METHODS: A retrospective cohort from a single institution, from 2000 to 2015, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Viani, Gustavo Arruda, Faustino, Alexandre Ciufi, Danelichen, Anielle Freitas Bendo, Matsuura, Fernando Kojo, Neves, Leonardo Vicente Fay, Fernandes, Marco Henrique, Fernandes, Juliana Pavoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086709/
https://www.ncbi.nlm.nih.gov/pubmed/33948297
http://dx.doi.org/10.5603/RPOR.a2021.0002
_version_ 1783686560569360384
author Viani, Gustavo Arruda
Faustino, Alexandre Ciufi
Danelichen, Anielle Freitas Bendo
Matsuura, Fernando Kojo
Neves, Leonardo Vicente Fay
Fernandes, Marco Henrique
Fernandes, Juliana Pavoni
author_facet Viani, Gustavo Arruda
Faustino, Alexandre Ciufi
Danelichen, Anielle Freitas Bendo
Matsuura, Fernando Kojo
Neves, Leonardo Vicente Fay
Fernandes, Marco Henrique
Fernandes, Juliana Pavoni
author_sort Viani, Gustavo Arruda
collection PubMed
description BACKGROUND: The objective of this study was to assess the treatment outcomes and prognostic factors of elderly patients with locally advanced head and neck cancer (LAHNC) undergoing radiotherapy (RT). MATERIALS AND METHODS: A retrospective cohort from a single institution, from 2000 to 2015, including patients older than 65 years old with LAHNC (stage III–IVa) treated by RT combined or not with chemotherapy (CRT). Univariate and multivariate analysis (MVA) were performed to identify prognostic factors associated with overall survival (OS), cancer-specific survival (CS), and locoregional control (LRC). A p-value < 0.05 was considered significant. RESULTS: 220 patients with LAHNC and > 65 years of age were identified. The median follow-up was 3.8 years, the 3/5 years estimated OS, CS, and LRC rate was 40%/30%, 49%/34%, 76%/45%, respectively. In the univariate analysis, clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.035), Karnofsky performance status (KPS, 60–70, p = 0.03) and tumor site (other than vs. hypopharynx, p = 0.0001) were associated with lower OS. Patients with clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.015), N stage (N0/1 vs. N2/3, p = 0.04), (KPS 60–70, p = 0.04) and tumor site (other than vs. hypopharynx, p = 0.0001) had worst CS. For the LRC, clinical stage (III vs. IVa/b, p = 0.02), tumor stage (T1/2 vs. T3/4, p = 0.02), treatment type (CRT vs. RT, p = 0.02), RT technique (IMRT vs. 2DRT/3DRT, p = 0.0001), and tumor site (other than vs. hypopharynx, p = 0.02) were significant. In the MVA, KPS maintained significant for OS and CS. For LRC, clinical stage (Iva/b, p = 0.007), tumor stage (T3/4, p = 0.047) and radiotherapy technique other than IMRT (p = 0.0001) were significant. CONCLUSION: The OS, CS, and LRC were associated with several prognostic factors. The clinical performance was the main marker of OS and CS. Chemoradiation should be offered to selected elderly patients using IMRT to improve LRC.
format Online
Article
Text
id pubmed-8086709
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-80867092021-05-03 Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort Viani, Gustavo Arruda Faustino, Alexandre Ciufi Danelichen, Anielle Freitas Bendo Matsuura, Fernando Kojo Neves, Leonardo Vicente Fay Fernandes, Marco Henrique Fernandes, Juliana Pavoni Rep Pract Oncol Radiother Research Paper BACKGROUND: The objective of this study was to assess the treatment outcomes and prognostic factors of elderly patients with locally advanced head and neck cancer (LAHNC) undergoing radiotherapy (RT). MATERIALS AND METHODS: A retrospective cohort from a single institution, from 2000 to 2015, including patients older than 65 years old with LAHNC (stage III–IVa) treated by RT combined or not with chemotherapy (CRT). Univariate and multivariate analysis (MVA) were performed to identify prognostic factors associated with overall survival (OS), cancer-specific survival (CS), and locoregional control (LRC). A p-value < 0.05 was considered significant. RESULTS: 220 patients with LAHNC and > 65 years of age were identified. The median follow-up was 3.8 years, the 3/5 years estimated OS, CS, and LRC rate was 40%/30%, 49%/34%, 76%/45%, respectively. In the univariate analysis, clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.035), Karnofsky performance status (KPS, 60–70, p = 0.03) and tumor site (other than vs. hypopharynx, p = 0.0001) were associated with lower OS. Patients with clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.015), N stage (N0/1 vs. N2/3, p = 0.04), (KPS 60–70, p = 0.04) and tumor site (other than vs. hypopharynx, p = 0.0001) had worst CS. For the LRC, clinical stage (III vs. IVa/b, p = 0.02), tumor stage (T1/2 vs. T3/4, p = 0.02), treatment type (CRT vs. RT, p = 0.02), RT technique (IMRT vs. 2DRT/3DRT, p = 0.0001), and tumor site (other than vs. hypopharynx, p = 0.02) were significant. In the MVA, KPS maintained significant for OS and CS. For LRC, clinical stage (Iva/b, p = 0.007), tumor stage (T3/4, p = 0.047) and radiotherapy technique other than IMRT (p = 0.0001) were significant. CONCLUSION: The OS, CS, and LRC were associated with several prognostic factors. The clinical performance was the main marker of OS and CS. Chemoradiation should be offered to selected elderly patients using IMRT to improve LRC. Via Medica 2021-02-25 /pmc/articles/PMC8086709/ /pubmed/33948297 http://dx.doi.org/10.5603/RPOR.a2021.0002 Text en © 2021 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
spellingShingle Research Paper
Viani, Gustavo Arruda
Faustino, Alexandre Ciufi
Danelichen, Anielle Freitas Bendo
Matsuura, Fernando Kojo
Neves, Leonardo Vicente Fay
Fernandes, Marco Henrique
Fernandes, Juliana Pavoni
Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
title Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
title_full Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
title_fullStr Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
title_full_unstemmed Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
title_short Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
title_sort radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086709/
https://www.ncbi.nlm.nih.gov/pubmed/33948297
http://dx.doi.org/10.5603/RPOR.a2021.0002
work_keys_str_mv AT vianigustavoarruda radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort
AT faustinoalexandreciufi radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort
AT danelichenaniellefreitasbendo radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort
AT matsuurafernandokojo radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort
AT nevesleonardovicentefay radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort
AT fernandesmarcohenrique radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort
AT fernandesjulianapavoni radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort